A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

NCT00930514 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Follicular

Interventions

DRUG: Rituximab
DRUG: Rituximab
DRUG: Rituximab
DRUG: Rituximab
DRUG: Rituximab

Sponsor

Hoffmann-La Roche